
Conference Coverage
2 days ago
AOA 2026: Do researchers lie?Latest Content

AOA 2026: Integrating AI into everyday eye care practice

Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals

Bausch + Lomb survey finds dry eye symptoms linked to emotional health impacts

Dry Eye Awareness Month: Building a strong optometry-ophthalmology comanagement model

AOA 2026: Burnout in optometry on par with health care industry trends

Shorts










Podcasts
Videos
Optometry Times Digital Edition





Continuing Medical Education
All News

In this podcast, retina specialist John Kitchens, MD, has a conversation with a patient about the choice he made for anti-VEGF therapy to reduce his treatment burden, then discusses recent clinical trial data on therapeutic options with extended treatment intervals.

Kaleb Abbott, OD, MS, FAAO, FOWNS, details one of his lectures during AOA's Optometry's Meeting 2026.

Jacqueline Theis, OD, FAAO, gave tips to clinicians on how to critically read studies in order to assess if they are applicable to their everyday practice.

Denise Whittam, OD, said that the Acuvue Oasys lens family holds her go-to lenses for patients for their comfortability.

Kaleb Abbott, OD, MS, FAAO, FOWNS, outlined a recent study he conducted with Neda Gioia OD, CNS, IFMCP, FOWNS, on optometry and burnout – in addition to unpublished data on job satisfaction.

Choosing the right patients for soft lenses, orthokeratology, and spectacle lenses has long-lasting effects on the vision health of those with myopia.

FDA clears Lumvoa for active and chronic thyroid eye disease, offering rapid proptosis and diplopia gains—plus key safety monitoring tips.

Canto-Sims, OD, discusses how Meta's donation of free AI glasses to blind veterans could close longstanding access gaps in low vision care.

Erin Rueff, OD, PhD, FAAO, provides an introduction to Johnson & Johnson's versatile contact lens family.

Jacqueline Theis, OD, FAAO, underscored the importance of individualizing care based on where the patient is in their MS journey.

Mark Schaeffer, OD, FAAO, stated that optometrists should be prepared for even the rarest cases of emergencies and urgencies.

ZEISS partners with Envision to expand evidence-backed VR perimetry, enabling more accessible, gamified home visual field testing for glaucoma monitoring.

The resubmission is considered a Class 1 submission and has a current PDUFA target action date of July 29, 2026.

Raman Bhakhri, OD, FAAO, outlines the biomarkers that optometrists should keep in their wheelhouse when examining patients.

Melody Tavakoli, OD, stated that patient complicance remains one of the biggest challenges for contact lens wearers.











































